APPLICATION SITE URTICARIA

This adverse event was reported 2247 times

These drugs are most commonly taken by patients reporting APPLICATION SITE URTICARIA:

# Drug Count
0 NICOTINE 445
1 BUPRENORPHINE 205
2 ESTRADIOL 195
3 METHYLPHENIDATE 140
4 NICOTINE POLACRILEX 84
5 ESTRADIOL GEL 0.1% 47
6 ESTRADIOL TRANSDERMAL 47
7 ESTRADIOL, 47
8 LEVOTHYROXINE SODIUM 43
9 SELEGILINE 42
See all common drugs associated with APPLICATION SITE URTICARIA

APPLICATION SITE URTICARIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Monoamine Oxidase Inhibitor [EPC] 42 0.0136
1 Cholinergic Nicotinic Agonist [EPC] 493 0.0081
2 Tubulin Inhibiting Agent [EPC] 1 0.0034
3 Partial Opioid Agonist [EPC] 205 0.0022
4 Nonergot Dopamine Agonist [EPC] 30 0.0019
5 Central Nervous System Stimulant [EPC] 148 0.0017
6 Estrogen [EPC] 242 0.0013
7 Provitamin D2 Compound [EPC] 35 0.0012
8 Aryl Hydrocarbon Receptor Agonist [EPC] 2 0.0010
9 Progesterone [EPC] 23 0.0010
See all drug classes enriched for association with APPLICATION SITE URTICARIA